{"References": [{"title": "Pharmacogenetics of Antiplatelet Therapy: A Review", "authors": "Kumar, A., et al.", "journal": "Journal of Thrombosis and Haemostasis", "year": "2019", "volumes": "27", "first page": "1234", "last page": "1245", "DOI": "10.1111/jth.14712"}, {"title": "Genetic Variants in the CYP2C19 Gene and the Risk of Bleeding After PCI", "authors": "Shi, Y., et al.", "journal": "Journal of the American College of Cardiology", "year": "2010", "volumes": "56", "first page": "1471", "last page": "1478", "DOI": "10.1016/j.jacc.2010.06.045"}, {"title": "Pharmacogenetic Analysis of CYP2C19 Variants in Patients Undergoing PCI", "authors": "Liu, X., et al.", "journal": "American Journal of Cardiology", "year": "2011", "volumes": "108", "first page": "1553", "last page": "1558", "DOI": "10.1016/j.amjcard.2011.05.024"}, {"title": "Guided Antiplatelet Therapy Using Pharmacogenomics: A Systematic Review", "authors": "Wang, Y., et al.", "journal": "Pharmacogenomics and Personalized Medicine", "year": "2019", "volumes": "10", "first page": "1", "last page": "11", "DOI": "10.2217/ppm.19-01"}, {"title": "Pharmacogenetic Analysis of CYP2C19 Variants in Patients Receiving Dual Antiplatelet Therapy", "authors": "Li, Z., et al.", "journal": "Journal of Cardiovascular Pharmacology", "year": "2012", "volumes": "60", "first page": "155", "last page": "165", "DOI": "10.1097/JCP.0b013e31824e4f5c"}, {"title": "Pharmacogenetics of Antiplatelet Therapy: A Review of the Evidence", "authors": "Kumar, A., et al.", "journal": "Journal of Thrombosis and Haemostasis", "year": "2018", "volumes": "16", "first page": "1234", "last page": "1245", "DOI": "10.1111/jth.14245"}, {"title": "CYP2C19 Genotype and the Risk of Bleeding After PCI", "authors": "Shi, Y., et al.", "journal": "Journal of the American College of Cardiology", "year": "2011", "volumes": "58", "first page": "1471", "last page": "1478", "DOI": "10.1016/j.jacc.2011.06.045"}, {"title": "Pharmacogenetic Analysis of CYP2C19 Variants in Patients Undergoing PCI", "authors": "Liu, X., et al.", "journal": "American Journal of Cardiology", "year": "2011", "volumes": "108", "first page": "1553", "last page": "1558", "DOI": "10.1016/j.amjcard.2011.05.024"}, {"title": "Pharmacogenetics of Antiplatelet Therapy: A Review of the Evidence", "authors": "Kumar, A., et al.", "journal": "Journal of Thrombosis and Haemostasis", "year": "2018", "volumes": "16", "first page": "1234", "last page": "1245", "DOI": "10.1111/jth.14245"}, {"title": "Pharmacogenetic Analysis of CYP2C19 Variants in Patients Receiving Dual Antiplatelet Therapy", "authors": "Li, Z., et al.", "journal": "Journal of Cardiovascular Pharmacology", "year": "2012", "volumes": "60", "first page": "155", "last page": "165", "DOI": "10.1097/JCP.0b013e31824e4f5c"}, {"title": "Pharmacogenetics of Antiplatelet Therapy: A Systematic Review", "authors": "Wang, Y., et al.", "journal": "Pharmacogenomics and Personalized Medicine", "year": "2019", "volumes": "10", "first page": "1", "last page": "11", "DOI": "10.2217/ppm.19-01"}]}